PATENT CLAIM ANALYSIS

Application Number: 15759588
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "587000"]

Abstract:
Provided is a compound activating RORα gene, particularly a JC1 compound containing CGP52608 thiazolidinedione as a lead substance, and a pharmaceutically acceptable salt thereof. The compound is a lipid accumulation inhibitor and applicable to the treatment of metabolic diseases or inflammatory diseases.

Claim (Index 14):
The method of  claim 11 , wherein the metabolic disease is alcoholic fatty liver.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.31429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14808269', '12430397', '15325791', '12474799', '12516944']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7829733359217319
- 35 USC 102 Novelty (BERT): 0.5046709033522869
- Combined Prediction Score: 0.7551430926647874
- Mean Citation Score: 245.58406800000003
- Max Citation Score: 249.09589
- Similarity Product: 172.11949544754742

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test